From Discovery to Impact: Advancing Therapeutics for Substance Use Disorders
Talk Description This presentation will outline the mission, structure, and impact of the Division of Therapeutics and Medical Consequences (DTMC), established in response to a 1989 Congressional mandate to advance medication development for substance use disorders (SUDs). It will describe how DTMC, modeled after a virtual pharmaceutical company, supports all phases of therapeutic development—from discovery […]

